Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Mechanisms, causes, and effects of hypercapnia

David J Feller-Kopman, MD
Richard M Schwartzstein, MD
Section Editor
James K Stoller, MD, MS
Deputy Editor
Geraldine Finlay, MD


Hypercapnia, defined as an elevation in the arterial carbon dioxide tension, is commonly encountered during the evaluation of patients with dyspnea and/or altered sensorium. Understanding the mechanisms, causes, and effects of hypercapnia is critical to its management.

The relevant physiology of ventilatory control, mechanisms, causes, and effects of hypercapnia are presented in this topic review. The evaluation and treatment of patients with acute hypercapnia are presented separately. (See "The evaluation, diagnosis, and treatment of the adult patient with acute hypercapnic respiratory failure".)


The partial pressure of carbon dioxide in arterial blood (PaCO2) is directly proportional to the rate of carbon dioxide (CO2) production (VCO2) by oxidative metabolism and indirectly proportional to the rate of CO2 elimination by the lung (alveolar ventilation; VA). Alveolar ventilation is the component of the expired minute volume that reaches perfused alveoli, and is in turn determined by minute ventilation (VE) and the ratio of dead space (VD) to tidal volume (VT) or VD/VT.

The following calculation is used to determine the PaCO2:

 PaCO2  =  (k)  x  VCO2/[VE(1  -  VD/VT)]

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information on subscription options, click below on the option that best describes you:

Subscribers log in here

Literature review current through: Oct 2017. | This topic last updated: Sep 08, 2017.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2017 UpToDate, Inc.
  1. Williams MH Jr, Shim CS. Ventilatory failure. Etiology and clinical forms. Am J Med 1970; 48:477.
  2. West JB. Causes of carbon dioxide retention in lung disease. N Engl J Med 1971; 284:1232.
  3. Weinberger SE, Schwartzstein RM, Weiss JW. Hypercapnia. N Engl J Med 1989; 321:1223.
  4. Sorli J, Grassino A, Lorange G, Milic-Emili J. Control of breathing in patients with chronic obstructive lung disease. Clin Sci Mol Med 1978; 54:295.
  5. Javaheri S, Blum J, Kazemi H. Pattern of breathing and carbon dioxide retention in chronic obstructive lung disease. Am J Med 1981; 71:228.
  6. Parot S, Miara B, Milic-Emili J, Gautier H. Hypoxemia, hypercapnia, and breathing pattern in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1982; 126:882.
  7. Aubier M, Murciano D, Fournier M, et al. Central respiratory drive in acute respiratory failure of patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1980; 122:191.
  8. O'Donnell DE, Ora J, Webb KA, et al. Mechanisms of activity-related dyspnea in pulmonary diseases. Respir Physiol Neurobiol 2009; 167:116.
  9. Aubier M, Murciano D, Milic-Emili J, et al. Effects of the administration of O2 on ventilation and blood gases in patients with chronic obstructive pulmonary disease during acute respiratory failure. Am Rev Respir Dis 1980; 122:747.
  10. Dick CR, Liu Z, Sassoon CS, et al. O2-induced change in ventilation and ventilatory drive in COPD. Am J Respir Crit Care Med 1997; 155:609.
  11. Christiansen J, Douglas CG, Haldane JS. The absorption and dissociation of carbon dioxide by human blood. J Physiol 1914; 48:244.
  12. Hanson CW 3rd, Marshall BE, Frasch HF, Marshall C. Causes of hypercarbia with oxygen therapy in patients with chronic obstructive pulmonary disease. Crit Care Med 1996; 24:23.
  13. Robinson TD, Freiberg DB, Regnis JA, Young IH. The role of hypoventilation and ventilation-perfusion redistribution in oxygen-induced hypercapnia during acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 161:1524.
  14. Crossley DJ, McGuire GP, Barrow PM, Houston PL. Influence of inspired oxygen concentration on deadspace, respiratory drive, and PaCO2 in intubated patients with chronic obstructive pulmonary disease. Crit Care Med 1997; 25:1522.
  15. Campbell EJ. The J. Burns Amberson Lecture. The management of acute respiratory failure in chronic bronchitis and emphysema. Am Rev Respir Dis 1967; 96:626.
  16. PRICE HL. Effects of carbon dioxide on the cardiovascular system. Anesthesiology 1960; 21:652.
  17. Juan G, Calverley P, Talamo C, et al. Effect of carbon dioxide on diaphragmatic function in human beings. N Engl J Med 1984; 310:874.
  18. Kazemi H. Cerebrospinal fluid and the control of ventilation. In: The Lung: Scientific Foundations, 2nd ed, Crystal RG, West JB, Weibel ER, Barnes PJ (Eds), Lippincott-Raven Publishers, Philadelphia 1997. p.1777.